X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Gillette India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs GILLETTE INDIA - Comparison Results

GILLETTE INDIA 
   Change

Gillette India is the 52% subsidiary of US shaving major - Gillette USA. The company came back into the black in 2003 after a spate of restructuring in 2001 and 2002. Gillette hived off its battery manufacturing plant (Duracell) at Manesar and also s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES GILLETTE INDIA AMAR REMEDIES/
GILLETTE INDIA
 
P/E (TTM) x -0.5 95.3 - View Chart
P/BV x 0.1 33.2 0.2% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 AMAR REMEDIES   GILLETTE INDIA
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
GILLETTE INDIA
Jun-18
AMAR REMEDIES/
GILLETTE INDIA
5-Yr Chart
Click to enlarge
High Rs1647,197 2.3%   
Low Rs865,002 1.7%   
Sales per share (Unadj.) Rs261.6514.5 50.8%  
Earnings per share (Unadj.) Rs17.470.3 24.7%  
Cash flow per share (Unadj.) Rs22.383.3 26.8%  
Dividends per share (Unadj.) Rs023.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs100.7213.0 47.3%  
Shares outstanding (eoy) m26.1632.59 80.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.511.9 4.0%   
Avg P/E ratio x7.286.8 8.3%  
P/CF ratio (eoy) x5.673.3 7.7%  
Price / Book Value ratio x1.228.6 4.3%  
Dividend payout %032.7 0.0%   
Avg Mkt Cap Rs m3,270198,775 1.6%   
No. of employees `000NA0.6 0.0%   
Total wages/salary Rs m1631,179 13.8%   
Avg. sales/employee Rs ThNM27,002.4-  
Avg. wages/employee Rs ThNM1,898.7-  
Avg. net profit/employee Rs ThNM3,688.4-  
INCOME DATA
Net Sales Rs m6,84416,769 40.8%  
Other income Rs m21128 16.5%   
Total revenues Rs m6,86516,896 40.6%   
Gross profit Rs m1,1313,816 29.6%  
Depreciation Rs m128423 30.3%   
Interest Rs m39875 533.5%   
Profit before tax Rs m6263,446 18.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1211,156 10.5%   
Profit after tax Rs m4552,291 19.9%  
Gross profit margin %16.522.8 72.6%  
Effective tax rate %19.333.5 57.6%   
Net profit margin %6.613.7 48.7%  
BALANCE SHEET DATA
Current assets Rs m4,9046,742 72.7%   
Current liabilities Rs m3,5814,794 74.7%   
Net working cap to sales %19.311.6 166.4%  
Current ratio x1.41.4 97.4%  
Inventory Days Days12444 285.2%  
Debtors Days Days10038 261.4%  
Net fixed assets Rs m1,6893,048 55.4%   
Share capital Rs m262326 80.4%   
"Free" reserves Rs m2,3586,616 35.6%   
Net worth Rs m2,6356,942 38.0%   
Long term debt Rs m5070-   
Total assets Rs m6,86212,090 56.8%  
Interest coverage x2.647.2 5.5%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.4 71.9%   
Return on assets %12.419.6 63.5%  
Return on equity %17.333.0 52.3%  
Return on capital %31.050.7 61.1%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2732,782 9.8%   
Fx outflow Rs m25,079 0.0%   
Net fx Rs m271-2,296 -11.8%   
CASH FLOW
From Operations Rs m-3132,371 -13.2%  
From Investments Rs m-489-768 63.6%  
From Financial Activity Rs m769-392 -195.9%  
Net Cashflow Rs m-331,211 -2.7%  

Share Holding

Indian Promoters % 25.5 34.9 73.1%  
Foreign collaborators % 0.0 40.1 -  
Indian inst/Mut Fund % 9.2 0.9 1,022.2%  
FIIs % 0.0 7.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 16.3 400.6%  
Shareholders   13,061 18,623 70.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   BAJAJ CONSUMER CARE  GODREJ CONSUMER  RELAXO FOOTWEARS  EMAMI LTD  KARUTURI GLOBAL  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Opens Flat; Capital Goods and Realty Stocks Lag(09:30 am)

Asian share markets are mixed today. The Shanghai Composite is lower by 0.3% while the Hang Seng is even. The Nikkei 225 is trading down by 0.7%.

Related Views on News

GILLETTE INDIA Announces Quarterly Results (4QFY19); Net Profit Up 23.1% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, GILLETTE INDIA has posted a net profit of Rs 878 m (up 23.1% YoY). Sales on the other hand came in at Rs 5 bn (up 3.1% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.

GILLETTE INDIA Announces Quarterly Results (3QFY19); Net Profit Down 8.1% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, GILLETTE INDIA has posted a net profit of Rs 540 m (down 8.1% YoY). Sales on the other hand came in at Rs 5 bn (up 16.7% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.

GILLETTE INDIA Announces Quarterly Results (2QFY19); Net Profit Up 1.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, GILLETTE INDIA has posted a net profit of Rs 654 m (up 1.6% YoY). Sales on the other hand came in at Rs 5 bn (up 11.9% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.

GILLETTE INDIA Announces Quarterly Results (4QFY18); Net Profit Down 32.6% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, GILLETTE INDIA has posted a net profit of Rs 713 m (down 32.6% YoY). Sales on the other hand came in at Rs 5 bn (down 15.5% YoY). Read on for a complete analysis of GILLETTE INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS